Close Menu

NEW YORK – Newomics said on Tuesday that it has closed a $7.9 million Series B funding round.

The round was led by MSA Capital, with new investor LDV Partners and existing investors including the Berkeley Catalyst Fund and the Photon Fund also participating.

Berkeley, California-based Newomics said it will use proceeds from the round to further commercialize products based on its mass spec multinozzle emitter array (MEA) technology, grow its sales and marketing as well as customer support teams, and expand collaborations with mass spec vendors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.